KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Gross Margin (2016 - 2025)

Resmed (RMD) has disclosed Gross Margin for 17 consecutive years, with 61.76% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin rose 316.0% year-over-year to 61.76%, compared with a TTM value of 60.87% through Dec 2025, up 248.0%, and an annual FY2025 reading of 59.36%, up 269.0% over the prior year.
  • Gross Margin was 61.76% for Q4 2025 at Resmed, roughly flat from 61.46% in the prior quarter.
  • Across five years, Gross Margin topped out at 61.76% in Q4 2025 and bottomed at 54.44% in Q3 2023.
  • Average Gross Margin over 5 years is 57.54%, with a median of 57.02% recorded in 2022.
  • The sharpest move saw Gross Margin tumbled -247bps in 2023, then surged 414bps in 2024.
  • Year by year, Gross Margin stood at 56.36% in 2021, then dropped by 0bps to 56.08% in 2022, then decreased by -1bps to 55.64% in 2023, then grew by 5bps to 58.6% in 2024, then increased by 5bps to 61.76% in 2025.
  • Business Quant data shows Gross Margin for RMD at 61.76% in Q4 2025, 61.46% in Q3 2025, and 60.84% in Q2 2025.